Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Matthew F, Pullen"'
Publikováno v:
Journal of Fungi, Vol 8, Iss 8, p 824 (2022)
Blastomycosis, caused by Blastomyces spp., is an endemic mycosis capable of causing significant disease throughout the body. Higher rates of infection are seen in the Mississippi and Ohio River valleys, the Great Lakes region of the United States and
Externí odkaz:
https://doaj.org/article/4d6a78ecfe1949519a773bb1d53fb544
Autor:
R. Adetunji Bakare, John F. Mulcahy, Matthew F. Pullen, Ryan T. Demmer, Sara L. Cox, Julie A. Thurn, Alison L. Galdys
Publikováno v:
Infection Control & Hospital Epidemiology. :1-5
Objective: Healthcare workers (HCWs) in long-term care facilities (LTCFs) are disproportionately affected by severe acute respiratory coronavirus virus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). To characterize factors
Autor:
Carolyn T, Bramante, Jared D, Huling, Christopher J, Tignanelli, John B, Buse, David M, Liebovitz, Jacinda M, Nicklas, Kenneth, Cohen, Michael A, Puskarich, Hrishikesh K, Belani, Jennifer L, Proper, Lianne K, Siegel, Nichole R, Klatt, David J, Odde, Darlette G, Luke, Blake, Anderson, Amy B, Karger, Nicholas E, Ingraham, Katrina M, Hartman, Via, Rao, Aubrey A, Hagen, Barkha, Patel, Sarah L, Fenno, Nandini, Avula, Neha V, Reddy, Spencer M, Erickson, Sarah, Lindberg, Regina, Fricton, Samuel, Lee, Adnin, Zaman, Hanna G, Saveraid, Walker J, Tordsen, Matthew F, Pullen, Michelle, Biros, Nancy E, Sherwood, Jennifer L, Thompson, David R, Boulware, Thomas A, Murray, Lena, Zinkl
Publikováno v:
New England Journal of Medicine. 387:599-610
Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.In this phase 3, double-blind, randomized, plac
Autor:
Ananta S Bangdiwala, Ilan S. Schwartz, Matthew F Pullen, Melanie R. Nicol, Alanna A Nascene, Sarah M Lofgren, Matthew P. Cheng, Sylvain A. Lother, David R. Boulware, Darlisha A. Williams, Katelyn A Pastick, Darlette Luke, Caleb P Skipper, Mahsa Abassi, Radha Rajasingham, Lauren E. Kelly, Glen Drobot, Katherine Huppler Hullsiek, Elizabeth C Okafor, Nicole S Engen, Lauren J. MacKenzie, Todd C. Lee, Emily G. McDonald, Ryan Zarychanski
Publikováno v:
Annals of Internal Medicine. 173:623-631
BACKGROUND: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19). OBJECTIVE: To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients. DESIGN: Randomized, double-blind, placebo-controlled
Autor:
Enock Kagimu, David B. Meya, Michael Okirwoth, Fiona V Cresswell, Ananta S Bangdiwala, Emily Martyn, Gavin Stead, Matthew F Pullen, Morris K Rutakingirwa, Vincent Wadda, Tyler D. Bold, Nathan C. Bahr, David R. Boulware, John Kasibante
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background The World Health Organization recommends GeneXpert MTB/RIF Ultra (Xpert Ultra), a fully automated polymerase chain reaction (PCR) assay, as the initial tuberculous meningitis (TBM) diagnostic test. The assay’s PCR cycle threshold (Ct) va
Autor:
Sarah M Lofgren, Ryan Zarychanski, David R. Boulware, Kathy H. Hullsiek, Derek LaBar, Emily G. McDonald, Matthew P. Cheng, Sylvain A. Lother, Katelyn A Pastick, Matthew F Pullen, Alanna A Nascene, Nicole Marten, Elizabeth C Okafor, Caleb P Skipper, Todd C. Lee, Lauren J. MacKenzie, Mahsa Abassi, Glen Drobot, Radha Rajasingham, Melanie R. Nicol, Lauren E. Kelly, Nicole W. Engen, Ilan S. Schwartz, Ananta S. Bangdiwala
Publikováno v:
New England Journal of Medicine
Coronavirus disease 2019 (Covid-19) occurs after exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the standard of care is observation and quarantine. Whether hydroxychloroquine can prevent symptom
Autor:
Darlisha A. Williams, Katelyn A Pastick, Tyler D. Bold, Sarah M Lofgren, Lindsey Collins, Nicole Engen, David R. Boulware, Katherine Huppler Hullsiek, Caleb P Skipper, Ananta S Bangdiwala, Radha Rajasingham, Beth K Thielen, Margaret L Axelrod, Melanie R. Nicol, Elizabeth C Okafor, Matthew F Pullen, Alanna A Colette
Publikováno v:
Open Forum Infectious Diseases
Background During the Covid-19 pandemic, clinical trials necessitated rapid testing to be performed remotely. Dried blood spot (DBS) techniques have enabled remote HIV virologic testing globally and more recently, antibody testing as well. We evaluat
Autor:
Radha Rajasingham, David R. Boulware, Sarah M Lofgren, Caleb P Skipper, Ananta S Bangdiwala, Alanna A Nascene, Katherine Huppler Hullsiek, Elizabeth C Okafor, Nicole Engen, Matthew F Pullen, Emily G. McDonald, Todd C. Lee, Mahsa Abassi, Darlisha A. Williams, Katelyn A Pastick
Publikováno v:
Open Forum Infectious Diseases
As the severe acute respiratory syndrome coronavirus 2 pandemic evolved, it was apparent that well designed and rapidly conducted randomized clinical trials were urgently needed. However, traditional clinical trial design presented several challenges
Autor:
Nicole Engen, David R. Boulware, Glen Drobot, Michael S Silverman, Matthew P. Cheng, Mahsa Abassi, Radha Rajasingham, Lauren E. Kelly, Ilan S. Schwartz, Ryan Zarychanshi, Emily G. McDonald, Elizabeth C Okafor, Sylvian A Lother, Nicole Marten, Sarah M Lofgren, Lauren J. MacKenzie, Alanna A Nascene, Ananta S Bangdiwala, Matthew F Pullen, Katherine Huppler Hullsiek, Melanie R. Nicol, Todd C. Lee, Margaret L Axelrod, Caleb P Skipper, Darlisha A. Williams, Katelyn A Pastick, Zain Chagla
Publikováno v:
Open Forum Infectious Diseases
medRxiv
medRxiv
Background Use of hydroxychloroquine in hospitalized patients with coronavirus disease 2019 (COVID-19), especially in combination with azithromycin, has raised safety concerns. Here, we report safety data from 3 outpatient randomized clinical trials.
Autor:
Darlisha A. Williams, Katelyn A Pastick, Peter Li, Sarah M Lofgren, Ingrid A. Mayer, Radha Rajasingham, Nicole Engen, Brian I. Rini, Emily G. McDonald, Caleb P Skipper, Stephen J. Dunlop, Alanna A Nascene, Elizabeth C Okafor, Todd C. Lee, David R. Boulware, Lauren J. MacKenzie, Margaret L Axelrod, Justin M. Balko, Katherine Huppler Hullsiek, Ananta S Bangdiwala, Melanie R. Nicol, Matthew F Pullen
Publikováno v:
medRxiv
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly emerging virus causing the ongoing Covid-19 pandemic with no known effective prophylaxis. We investigated whether hydroxychloroquine could prevent SARS CoV-2 in healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::786899cb25e220a56eb82c8492405c07
https://doi.org/10.1101/2020.09.18.20197327
https://doi.org/10.1101/2020.09.18.20197327